Patient demographics and baseline tumor characteristics
| Anastrozole | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 mg/day (n = 12) | 10 mg/day (n = 12) | |||||||
| Age (yr)a | 74.1 ± 8.7 | 68.8 ± 8.9 | ||||||
| Weight (kg)a | 69.6 ± 9.6 | 77.5 ± 14.2 | ||||||
| Height (cm)a | 156.3 ± 12.2 | 157.8 ± 11.7 | ||||||
| Tumor stageb | ||||||||
| T2 | 11 | (91.7) | 10 | (83.3) | ||||
| T3 | 0 | (0) | 2 | (16.7) | ||||
| T4B | 1 | (8.3) | 0 | (0) | ||||
| Lymph node metastases | 2 | (16.7) | 1 | (8.3) | ||||
| Tumor volume assessment (cm3) | ||||||||
| Caliper | ||||||||
| Median | 23.7 | 27.3 | ||||||
| Maximum | 42.4 | 161.0 | ||||||
| Minimum | 12.4 | 10.9 | ||||||
| Ultrasound | ||||||||
| Median | 4.8 | 4.9 | ||||||
| Maximum | 9.9 | 14.3 | ||||||
| Minimum | 2.4 | 1.4 | ||||||
| Mammography | ||||||||
| Median | 7.3 | 8.4 | ||||||
| Maximum | 25.5 | 47.7 | ||||||
| Minimum | 1.4 | 0.7 | ||||||
a Mean ± SD.
b No. of patients, with percentage in parens.